Literature DB >> 8159977

Carcinogenicity of trace elements with reference to evaluations made by the International Agency for Research on Cancer.

P Boffetta1.   

Abstract

The monograph program of the International Agency for Research of on Cancer has evaluated many trace elements for their carcinogenicity to humans. Five groups of compounds were considered human carcinogens: arsenic and arsenic compounds, beryllium and beryllium compounds, cadmium and cadmium compounds, hexavalent chromium compounds, and nickel compounds. Antimony trioxide, cobalt and cobalt compounds, lead and inorganic lead compounds, methylmercury compounds, and metallic nickel were considered possibly carcinogenic to humans. Antimony trisulfide, trivalent chromium compounds, metallic chromium, ferric oxide, organolead compounds, metallic mercury, inorganic mercury compounds, selenium and selenium compounds, and titanium dioxide were not classifiable. Trace elements studied to a limited extent include copper, manganese, tin, vanadium, and zinc. Among the problems are the lack of relevant data, the definition of active species, the extrapolation of the results of experimental studies to humans, the methodological problems of epidemiologic studies, and the possible anticarcinogenic activity of some trace elements.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8159977

Source DB:  PubMed          Journal:  Scand J Work Environ Health        ISSN: 0355-3140            Impact factor:   5.024


  11 in total

Review 1.  Occupational risk factors and pancreatic cancer: a review of recent findings.

Authors:  Gabriella Andreotti; Debra T Silverman
Journal:  Mol Carcinog       Date:  2012-01       Impact factor: 4.784

2.  Colorimetric cadmium ion detection in aqueous solutions by newly synthesized Schiff bases.

Authors:  Ziya Aydin; Mustafa KeleŞ
Journal:  Turk J Chem       Date:  2020-06-01       Impact factor: 1.239

3.  Metallomics study using hair mineral analysis and multiple logistic regression analysis: relationship between cancer and minerals.

Authors:  Hiroshi Yasuda; Kazuya Yoshida; Mitsuru Segawa; Ryoichi Tokuda; Toyoharu Tsutsui; Yuichi Yasuda; Shunichi Magara
Journal:  Environ Health Prev Med       Date:  2009-06-26       Impact factor: 3.674

4.  Study of cancer incidence among 6363 male workers in four Norwegian ferromanganese and silicomanganese producing plants.

Authors:  A Hobbesland; H Kjuus; D S Thelle
Journal:  Occup Environ Med       Date:  1999-09       Impact factor: 4.402

5.  Cadmium exposure and risk of pancreatic cancer: a meta-analysis of prospective cohort studies and case-control studies among individuals without occupational exposure history.

Authors:  Cheng Chen; Pengcheng Xun; Muneko Nishijo; Akira Sekikawa; Ka He
Journal:  Environ Sci Pollut Res Int       Date:  2015-10-01       Impact factor: 4.223

6.  Evacuation decisions in a chemical air pollution incident: cross sectional survey.

Authors:  S Kinra; G Lewendon; R Nelder; N Herriott; R Mohan; M Hort; S Harrison; V Murray
Journal:  BMJ       Date:  2005-06-25

7.  Cancer and occupational exposure to inorganic lead compounds: a meta-analysis of published data.

Authors:  H Fu; P Boffetta
Journal:  Occup Environ Med       Date:  1995-02       Impact factor: 4.402

8.  Trace elements and carcinogenicity: a subject in review.

Authors:  Stephen Juma Mulware
Journal:  3 Biotech       Date:  2012-06-10       Impact factor: 2.406

9.  Serum cadmium levels in pancreatic cancer patients from the East Nile Delta region of Egypt.

Authors:  Alison M Kriegel; Amr S Soliman; Qing Zhang; Nabih El-Ghawalby; Farouk Ezzat; Ahmed Soultan; Mohamed Abdel-Wahab; Omar Fathy; Gamal Ebidi; Nadia Bassiouni; Stanley R Hamilton; James L Abbruzzese; Michelle R Lacey; Diane A Blake
Journal:  Environ Health Perspect       Date:  2006-01       Impact factor: 9.031

10.  Risk of Cancer for Workers Exposed to Antimony Compounds: A Systematic Review.

Authors:  Anton Saerens; Manosij Ghosh; Jelle Verdonck; Lode Godderis
Journal:  Int J Environ Res Public Health       Date:  2019-11-14       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.